Evoke Pharma (EVOK) Reports Q2 Loss of $0.93/sh

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/28/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. SPY
6. META
7. BA
8. HOOD
9. INTC
10. JBLU

Go back to Evoke Pharma (EVOK) Reports Q2 Loss of $0.93/sh

Evoke Pharma, Inc. Reports Second Quarter 2024 Financial Results

August 13, 2024 8:00 AM EDT

GIMOTI second quarter net product sales grew 47% quarter-over-quarter and 126% year-over-year, indicating an annual run-rate in excess of $10 million

Achieved record-high prescription fills during Q2

75% year-over-year prescription fill increase; 32% growth compared to Q1 2024

Two abstracts submitted and accepted by the American College of Gastroenterology (ACG) focusing on use of GIMOTI in patients on GLP-1 analogs

SOLANA BEACH, Calif., Aug. 13, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty... More